Teva SantéAHZANTIVE 40 mg/ml Solution for injection prefilled syringe Syringe/0,09ml
CIP / EAN : 3400930327715
About Formycon
Formycon develops biosimilars, biological medicines developed by reference to already authorised treatments. The company distinguishes approved products from candidates that are still in development.
Its portfolio includes the FYB201 ranibizumab, FYB202 ustekinumab and FYB203 aflibercept programmes. It also presents research programmes involving pembrolizumab and dupilumab.
Associated catalogue products
1 reference
These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.
- Teva Santé
Your professional shop
Open the shop to sign in, view the terms available to your account and place your order.
Open the shop